Related Experiment Video
Updated: Aug 15, 2025
Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
Published on: January 5, 2016
Dual roles and potential applications of exosomes in HCV infections
Yiqian Yin1, Yuxue Zhao1, Qiaoqiao Chen1
1Department of Laboratory Medicine, Affiliated Kunshan Hospital of Jiangsu University, Suzhou, Jiangsu, China.
Insights
Exosomes play a dual role in hepatitis C virus (HCV) infections, potentially spreading the virus or delivering antiviral therapies. Understanding these extracellular vesicles is key for developing new HCV diagnostics and treatments.
Area of Science:
- Hepatology
- Virology
- Cell Biology
Background:
- Hepatitis C virus (HCV) causes severe liver disease, including cirrhosis and cancer.
- Current antibody therapies for HCV have limited success, suggesting alternative infection pathways.
- Exosomes, small vesicles involved in intercellular communication, are implicated in HCV pathogenesis.
Purpose of the Study:
- To review the multifaceted roles of exosomes in hepatitis C virus (HCV) infections.
- To explore the potential clinical applications of exosomes in diagnosing and treating HCV.
- To summarize current knowledge on exosome-mediated HCV transmission and therapeutic strategies.
Main Methods:
- Literature review of studies investigating exosomes and HCV.
- Analysis of exosome biogenesis and function in the context of viral infections.
- Synthesis of data on exosome content (nucleic acids, proteins) and their impact on HCV.
Main Results:
- Exosomes can facilitate HCV spread by transferring viral components and evading immune detection.
- Conversely, exosomes can carry antiviral molecules or modulate immune responses against HCV.
- Exosomes show promise for HCV diagnosis and as drug delivery vehicles for anti-HCV therapies.
Conclusions:
- Exosomes exhibit dual functions in HCV infection, acting as both facilitators and inhibitors.
- Exosomes represent a significant area for developing novel diagnostic biomarkers for HCV-related liver diseases.
- Targeting exosome-mediated pathways offers a promising avenue for future anti-HCV therapeutic interventions.
Abstract:
The hepatitis C virus (HCV) causes severe liver diseases, including hepatitis, liver cirrhosis, and hepatocellular carcinoma, which have high morbidity and mortality. Antibody targeting receptor-mediated HCV infections have limited therapeutic benefits, suggesting that the transmission of HCV infections is possibly mediated via receptor-independent mechanisms. Exosomes are membrane-enclosed vesicles with a diameter of 30-200 nm, which originate from the fusion of endosomal multivesicular bodies with the plasma membrane. Accumulating evidence suggests that exosomes have a pivotal role in HCV infections. Exosomes can transfer viral and cellular bioactive substances, including nucleic acids and proteins, to uninfected cells, thus spreading the infection by masking these materials from immunological recognition. In addition, exosomes originating from some cells can deliver antiviral molecules or prompt the immune response to inhibit HCV infection. Exosomes can be used for the diagnosis of HCV-related diseases, and are being presently evaluated as therapeutic tools for anti-HCV drug delivery. This review summarizes the current knowledge on the dual roles and potential clinical applications of exosomes in HCV infections.
